Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	48.43B
Revenue (ttm)	18.09B
Net Income (ttm)	1.35B
Shares Out	1.37B
EPS (ttm)	0.99
PE Ratio	35.74
Forward PE	34.79
Dividend	1.00 (2.83%)
Ex-Dividend Date	Jun 30, 2025

Volume	16,715,651
Average Volume	8,179,707
Open	35.23
Previous Close	35.02
Day's Range	35.10 - 35.87
52-Week Range	32.99 - 43.00
Beta	0.16
RSI	69.12
Earnings Date	Oct 31, 2025

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally. It operates through the Company, Science Company, Commerce Company, and Others segments. The company offers various product dosage forms, such as pills, powders, alcoholic preparations, capsules, oral liquids, and dripping pills. Its products are used for cardiovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive system, pediatrics, wind and dampness-removing, or...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,883
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2024, Beijing Tongrentang's revenue was 18.60 billion, an increase of 4.12% compared to the previous year's 17.86 billion. Earnings were 1.53 billion, a decrease of -8.54%.